News
Dr. Chagpar on Sequencing Therapies for HER2-Positive Breast Cancer
Anees B. Chagpar, MD, MA, MPH, MBA, FRCS(C), FACS, associate professor of surgery (oncology), director, The Breast Center at Smilow Cancer Hospital at Yale-New Haven, assistant director, Global Oncology, Yale Comprehensive Cancer Center, discusses sequencing therapies for patients with HER2-positive breast cancer. - See more at: http://www.onclive.com/onclive-tv/dr-chagpar-on-sequencing-therapies-for-her2-positive-breast-cancer#sthash.a664PVe7.dpuf
Source: OncLive